These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

50 related articles for article (PubMed ID: 20501362)

  • 1. [A non-infectious and quantitative cell-based bioassay for screening HIV entry inhibitors targeting HIV envelope proteins].
    Li MM; Xia CL; Mao QC; Jiang SB; Liu SW
    Nan Fang Yi Ke Da Xue Xue Bao; 2010 May; 30(5):941-4. PubMed ID: 20501362
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development and automation of a 384-well cell fusion assay to identify inhibitors of CCR5/CD4-mediated HIV virus entry.
    Bradley J; Gill J; Bertelli F; Letafat S; Corbau R; Hayter P; Harrison P; Tee A; Keighley W; Perros M; Ciaramella G; Sewing A; Williams C
    J Biomol Screen; 2004 Sep; 9(6):516-24. PubMed ID: 15452338
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rapid and automated fluorescence-linked immunosorbent assay for high-throughput screening of HIV-1 fusion inhibitors targeting gp41.
    Liu S; Boyer-Chatenet L; Lu H; Jiang S
    J Biomol Screen; 2003 Dec; 8(6):685-93. PubMed ID: 14711394
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [1,2,6-tri-O-galloyl-beta-D-glucopyranose inhibits gp41-mediated HIV envelope fusion with target cell membrane].
    Sun W; Wang HT; Xia CL; Wu SG; Jiang SB; Jiang ZH; Liu SW
    Nan Fang Yi Ke Da Xue Xue Bao; 2008 Jul; 28(7):1127-31. PubMed ID: 18676243
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A novel enzyme-linked immunosorbent assay for screening HIV-1 fusion inhibitors targeting HIV-1 Gp41 core structure.
    Pang W; Wang RR; Gao YD; Yang LM; Sun Y; Huang JF; Tien P; Zheng YT
    J Biomol Screen; 2011 Feb; 16(2):221-9. PubMed ID: 21297108
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antiviral properties of two trimeric recombinant gp41 proteins.
    Delcroix-Genête D; Quan PL; Roger MG; Hazan U; Nisole S; Rousseau C
    Retrovirology; 2006 Mar; 3():16. PubMed ID: 16515685
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CD4 activation of HIV fusion.
    Sattentau QJ
    Int J Cell Cloning; 1992 Nov; 10(6):323-32. PubMed ID: 1281202
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CD4 mimics targeting the mechanism of HIV entry.
    Yamada Y; Ochiai C; Yoshimura K; Tanaka T; Ohashi N; Narumi T; Nomura W; Harada S; Matsushita S; Tamamura H
    Bioorg Med Chem Lett; 2010 Jan; 20(1):354-8. PubMed ID: 19926478
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Heat-resistant factors in human erythrocyte membranes mediate CD4-dependent fusion with cells expressing HIV-1 envelope glycoproteins.
    Puri A; Morris SJ; Jones P; Ryan M; Blumenthal R
    Virology; 1996 May; 219(1):262-7. PubMed ID: 8623537
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HIV envelope glycoprotein-induced cell killing by apoptosis is enhanced with increased expression of CD26 in CD4+ T cells.
    Jacotot E; Callebaut C; Blanco J; Rivière Y; Krust B; Hovanessian AG
    Virology; 1996 Sep; 223(2):318-30. PubMed ID: 8806567
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Normal T cell receptor-mediated signaling in T cell lines stably expressing HIV-1 envelope glycoproteins.
    Tani Y; Tian H; Lane HC; Cohen DI
    J Immunol; 1993 Dec; 151(12):7337-48. PubMed ID: 7903106
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HIV-1 gp120/160 expressing cells upregulate HIV-1 LTR directed gene expression in a cell line transfected with HIV-1 LTR-reporter gene constructs.
    Merzouki A; Patel P; Cassol S; Ennaji M; Tailor P; Turcotte FR; O'Shaughnessy M; Arella M
    Cell Mol Biol (Noisy-le-grand); 1995 May; 41(3):445-52. PubMed ID: 7580840
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HIV-1 gp41: mediator of fusion and target for inhibition.
    Weiss CD
    AIDS Rev; 2003; 5(4):214-21. PubMed ID: 15012000
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A conserved molecular action of native and recombinant Epap-1 in inhibition of HIV-1 gp120 mediated viral entry.
    Roda Rani KP; Pelluru D; Kondapi AK
    Arch Biochem Biophys; 2006 Dec; 456(1):79-92. PubMed ID: 17078922
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential effects of a hydrophobic tripeptide on human immunodeficiency virus type 1 (HIV-1)-induced syncytium formation and viral infectivity.
    Konopka K; Pretzer E; Düzgünes N
    Biochem Biophys Res Commun; 1995 Mar; 208(1):75-81. PubMed ID: 7887968
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Downregulation of human immunodeficiency virus type 1 Gag expression by a gp41 cytoplasmic domain fusion protein.
    Chan WE; Chen SS
    Virology; 2006 May; 348(2):418-29. PubMed ID: 16472834
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Functional analysis of the disulfide-bonded loop/chain reversal region of human immunodeficiency virus type 1 gp41 reveals a critical role in gp120-gp41 association.
    Maerz AL; Drummer HE; Wilson KA; Poumbourios P
    J Virol; 2001 Jul; 75(14):6635-44. PubMed ID: 11413331
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Coexpression of a nonsyncytium inducer HIV-1 glycoprotein inhibits syncytium formation by another HIV-1 Env protein.
    Li YY; O'Donnell MA; Perez LG
    Virology; 1996 Jan; 215(2):197-202. PubMed ID: 8560767
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Syncytium induction by fresh HIV isolates: quantitative analysis using a transactivation beta-gal assay.
    Emilie D; Maillot MC; Bonnerot C; Devergne O; Delfraissy JF; Nicolas JF; Galanaud P
    AIDS; 1990 Aug; 4(8):791-7. PubMed ID: 1979746
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inefficient formation of a complex among CXCR4, CD4 and gp120 in U937 clones resistant to X4 gp120-gp41-mediated fusion.
    Xiao X; Norwood D; Feng YR; Moriuchi M; Jones-Trower A; Stantchev TS; Moriuchi H; Broder CC; Dimitrov DS
    Exp Mol Pathol; 2000 Jun; 68(3):139-46. PubMed ID: 10816382
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.